Literature DB >> 1740440

Myristoylation of proteins in the yeast secretory pathway.

S M Simon1, A Aderem.   

Abstract

Protein myristoylation was investigated in the yeast secretory pathway. Conditional secretory mutations were used to accumulate inteRmediaries in the pathway between the endoplasmic reticulum and Golgi (sec 18, 20), within the Golgi (sec 7), and between the Golgi and plasma membrane (sec 1, 3, 4, 5, 6, 8, 9). The accumulation of vesicles was paralleled by the enrichment of a defined subset of proteins modified either via ester or amide linkages to myristic acid: Myristoylated proteins of 21, 32, 49, 56, 75, and 136 kDa were enriched between the endoplasmic reticulum and Golgi; proteins of 21, 32, 45, 56, 75, 136 kDa were enriched by blocks within the Golgi; and proteins of 18, 21, 32, 36, 49, 68, and 136 kDa were trapped in a myristoylated form by blocks between the Golgi and plasma membrane. This enrichment of myristoylated proteins was reversed upon returning the cells to the permissive temperature for secretion. The fatty acid was linked to the 21-kDa protein via a hydroxylamine-resistant amide linkage (N-myristoylation) and to the proteins of 24, 32, 49, 56, 68, 136 kDa via hydroxylamine-labile ester linkage (E-myristoylation). In addition, myristoylated proteins of 21, 56, and 136 kDa were glycosylated via amino linkages to asparagine. This suggests they are exposed to the lumen of the secretory pathway. Three proteins (24, 32, and 56) were E-myristoylated in the presence of protein synthesis inhibitors, indicating this modification can occur posttranslationally. After using cycloheximide to clear protein passengers from the secretory pathway the 21-, 32-, and 56-kDa proteins continued to accumulate in a myristoylated form when vesicular transport was blocked between the Golgi and plasma membrane. These data suggest that myristoylation occurs on a component of the secretory machinery rather than on a passenger protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1740440

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Role for Arf3p in development of polarity, but not endocytosis, in Saccharomyces cerevisiae.

Authors:  Chun-Fang Huang; Ya-Wen Liu; Luh Tung; Chiou-Hong Lin; Fang-Jen S Lee
Journal:  Mol Biol Cell       Date:  2003-06-13       Impact factor: 4.138

2.  Fatty acid synthesis: a potential selective target for antineoplastic therapy.

Authors:  F P Kuhajda; K Jenner; F D Wood; R A Hennigar; L B Jacobs; J D Dick; G R Pasternack
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

3.  Pheromone action regulates G-protein alpha-subunit myristoylation in the yeast Saccharomyces cerevisiae.

Authors:  H G Dohlman; P Goldsmith; A M Spiegel; J Thorner
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

4.  Rab-mediated trafficking in the secondary cells of Drosophila male accessory glands and its role in fecundity.

Authors:  Elodie Prince; Benjamin Kroeger; Dragan Gligorov; Clive Wilson; Suzanne Eaton; François Karch; Marko Brankatschk; Robert K Maeda
Journal:  Traffic       Date:  2018-12-26       Impact factor: 6.215

5.  HP0953 - hypothetical virulence factor overexpresion and localization during Helicobacter pylori infection of gastric epithelium.

Authors:  Nancy K Arteaga-Resendiz; Gerardo E Rodea; Rosa María Ribas-Aparicio; Alma L Olivares-Cervantes; Juan Arturo Castelán-Vega; José de Jesús Olivares-Trejo; Sandra Mendoza-Elizalde; Edgar O López-Villegas; Christian Colín; Pamela Aguilar-Rodea; Alfonso Reyes-López; Marcela Salazar García; Norma Velázquez-Guadarrama
Journal:  World J Gastroenterol       Date:  2022-08-07       Impact factor: 5.374

6.  A Novel Two-Tag System for Monitoring Transport and Cleavage through the Classical Secretory Pathway - Adaptation to HIV Envelope Processing.

Authors:  Zachary D Stolp; Aleksandr Stotland; Samantha Diaz; Brett J Hilton; Wesley Burford; Roland Wolkowicz
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.